Marine Natural Products and Other Derivatives as Potent Indoleamine 2,3-Dioxygenase Inhibitors

被引：16

作者：

Delfourne, Evelyne ^{[1
]}

机构：

[1] Univ Paul Sabatier, UMR CNRS 5068, Lab Synth & Physicochim Mol Interet Biol, F-31062 Toulouse 9, France

来源：

MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2012年 / 12卷 / 10期

关键词：

Indoleamine 2,3-dioxygenase; IDO inhibitors; marine natural compounds; COMPETITIVE INHIBITORS; IMMUNE ESCAPE; EXIGUAMINE-A; TRYPTOPHAN; BINDING; TARGET; IDO; MECHANISM; CANCER;

D O I：

10.2174/138955712802762374

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Cancer cells are able to elaborate enzymatic mechanisms allowing tumors to resist or escape imune rejection. Among the enzymes involved, indoleamine 2,3-dioxygenase (IDO), an intracellular enzyme that initiates the first and rate-limiting step of tryptophan breakdown along the kynurenine pathway, has emerged as a promising molecular target for the development of new immunotherapeutic anticancer agents. This review summarizes the synthesis and IDO activities of the different classes of marine and other inhibitors reported so far.

引用

页码：988 / 996

页数：9

共 50 条

[1] Rational Design of Indoleamine 2,3-Dioxygenase Inhibitors
Roehrig, Ute F.
Awad, Loay
Grosdidier, Aurelien
Larrieu, Pierre
Stroobant, Vincent
Colau, Didier
Cerundolo, Vincenzo
Simpson, Andrew J. G.
Vogel, Pierre
Van den Eynde, Benoit J.
Zoete, Vincent
Michielin, Olivier
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (03) : 1172 - 1189
[2] Novel candesartan derivatives as indoleamine 2,3-dioxygenase inhibitors
Matsuno, Kenji
Yamazaki, Hiroshi
Isaka, Yoshinobu
Takai, Kazushige
Unno, Yuka
Ogo, Naohisa
Ishikawa, Yoshinobu
Fujii, Satoshi
Takikawa, Osamu
Asai, Akira
MEDCHEMCOMM, 2012, 3 (04) : 475 - 479
[3] Nitrobenzofurazan derivatives of N′-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1
Paul, Saurav
Roy, Ashalata
Deka, Suman Jyoti
Panda, Subhankar
Trivedi, Vishal
Manna, Debasis
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 121 : 364 - 375
[4] Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3-dioxygenase (IDO) inhibitors
Tanaka, Minoru
Li, Xin
Hikawa, Hidemasa
Suzuki, Takafumi
Tsutsumi, Katsuhiko
Sato, Masashi
Takikawa, Osamu
Suzuki, Hideharu
Yokoyama, Yuusaku
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (05) : 1159 - 1165
[5] S-Benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase
Matsuno, Kenji
Takai, Kazushige
Isaka, Yoshinobu
Unno, Yuka
Sato, Masayuki
Takikawa, Osamu
Asai, Akira
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (17) : 5126 - 5129
[6] Research progress of indoleamine 2,3-dioxygenase inhibitors
Jiang, Tianze
Sun, Yingying
Yin, Zhichao
Feng, Sen
Sun, Liping
Li, Zhiyu
FUTURE MEDICINAL CHEMISTRY, 2015, 7 (02) : 185 - 201
[7] Potent Activation of Indoleamine 2,3-Dioxygenase by Polysulfides
Nelp, Micah T.
Zheng, Vincent
Davis, Katherine M.
Stiefel, Katherine J. E.
Groves, John T.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, 141 (38) : 15288 - 15300
[8] Benzofuranquinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis and biological evaluation
Carvalho, Catarina
Siegel, David
Inman, Martyn
Xiong, Rui
Ross, David
Moody, Christopher J.
ORGANIC & BIOMOLECULAR CHEMISTRY, 2014, 12 (17) : 2663 - 2674
[9] Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2
Bakmiwewa, Supun M.
Fatokun, Amos A.
Anh Tran
Payne, Richard J.
Hunt, Nicholas H.
Ball, Helen J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (24) : 7641 - 7646
[10] Discovery and biological evaluation of tanshinone derivatives as potent dual inhibitors of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase
Liu, Jiangxin
Ren, Jian
Yang, Kun
Chen, Shuang
Yang, Xinni
Zhao, Qin-Shi
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 235

← 1 2 3 4 5 →